Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study will test the feasibility of combining 3 drugs, Revlimid with Doxil and
Bevacizumab,and gather preliminary data on the potential activity of the combination in
patients with platinum resistant/refractory ovarian cancer.